Why Europe Is Putting the Brakes on Gender Interventions: Leor Sapir

“The UK has now banned puberty blockers—probably will ban cross-sex hormones too, is my prediction, in the next few years,” said Leor Sapir, a fellow at the Manhattan Institute.

He has been following the massive increase in children identifying as transgender and undergoing what’s known as “gender-affirming care” treatment—from puberty blockers to double mastectomies.

“[The World Professional Association for Transgender Health] commissioned systematic evidence reviews as part of the process of developing [Standards of Care Version 8]. When it found out that the evidence reviews, specifically for minors, were unimpressive and did not get them the results that they wanted—that would support their medical approach, they suppressed them. They basically instructed the researchers at Johns Hopkins University who were doing these systematic reviews to not publish them,” said Sapir. “Any way you look at it, WPATH greatly deviated from how responsible, trustworthy medical guidelines are supposed to be developed.”

His current area of focus is the pushback to gender interventions for minors, including state bans, lawsuits, and a landmark case now at the Supreme Court.

“This case has tremendous consequences for what’s going to happen in the 26 states that have banned these interventions in minors,” said Sapir.

Views expressed in this video are opinions of the host and the guest, and do not necessarily reflect the views of The Epoch Times.